NO20035317D0 - Antineoplastic combinations - Google Patents

Antineoplastic combinations

Info

Publication number: NO20035317D0
Authority: NO; Norway
Prior art keywords: antineoplastic combinations; antineoplastic; combinations
Prior art date: 2001-06-01

Application number

NO20035317A

Other languages

Norwegian (no)

Other versions

NO20035317L (en

Inventor

Gary Dukart

Jr James Joseph Gibbons

Original Assignee

Wyeth Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-06-01

Filing date

2003-11-28

Publication date

2003-11-28

2003-11-28 Application filed by Wyeth Corp filed Critical Wyeth Corp

2003-11-28 Publication of NO20035317D0 publication Critical patent/NO20035317D0/en

2003-12-22 Publication of NO20035317L publication Critical patent/NO20035317L/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Inorganic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Hematology (AREA)
Oncology (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO20035317A 2001-06-01 2003-11-28 Antineoplastic combinations NO20035317L (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US29519001P	2001-06-01	2001-06-01
US29523601P	2001-06-01	2001-06-01
PCT/US2002/016737 WO2002098416A2 (en)	2001-06-01	2002-05-29	Antineoplastic combinations

Publications (2)

Publication Number	Publication Date
NO20035317D0 true NO20035317D0 (en)	2003-11-28
NO20035317L NO20035317L (en)	2003-12-22

Family

ID=26968972

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20035317A NO20035317L (en)	2001-06-01	2003-11-28	Antineoplastic combinations

Country Status (17)

Country	Link
EP (1)	EP1392286A2 (en)
JP (1)	JP2004532883A (en)
KR (1)	KR100875611B1 (en)
CN (1)	CN100496485C (en)
AU (2)	AU2002259309B2 (en)
BR (1)	BR0210101A (en)
CA (1)	CA2447732A1 (en)
CO (1)	CO5540294A2 (en)
EA (1)	EA007530B1 (en)
HU (1)	HUP0400006A2 (en)
IL (1)	IL158800A0 (en)
MX (1)	MXPA03010907A (en)
NO (1)	NO20035317L (en)
NZ (1)	NZ529877A (en)
PL (1)	PL367267A1 (en)
SG (1)	SG153647A1 (en)
WO (1)	WO2002098416A2 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2269603B1 (en)	2001-02-19	2015-05-20	Novartis AG	Treatment of breast tumors with a rapamycin derivative in combination with exemestane
UA83484C2 (en) *	2003-03-05	2008-07-25	Уайт	Method for treating breast cancer using combination of rapamycin derivative and aromatase inhibitor, pharmaceutical composition
AR046194A1 (en)	2003-11-04	2005-11-30	Mayo Foundation	TREATMENT METHOD OF MANTO CELL LYMPHOMA
KR101313702B1 (en)	2005-02-03	2013-10-04	와이어쓰	Pharmaceutical composition for treating gefitinib and／or erlotinib resistant cancer
TW200803892A (en) *	2005-11-04	2008-01-16	Wyeth Corp	Antineoplastic combinations with MTOR inhibitor, herceptin, and/or HKI-272
GB0523658D0 (en) *	2005-11-21	2005-12-28	Novartis Ag	Organic compounds
NO346575B1 (en) *	2005-11-21	2022-10-17	Novartis Ag	Use of 40-O-(2-hydroxyethyl)-rapamycin in the treatment of carcinoid or small cell cancer
US20090023768A1 (en) *	2006-02-24	2009-01-22	Novartis Ag	Rapamycin derivatives for treating neuroblastoma
RU2447891C2 (en) *	2006-04-05	2012-04-20	Новартис Аг	Combinations of therapeutic agents applicable for treating cancer
SI2131821T1 (en) *	2007-03-07	2018-11-30	Abraxis Bioscience, Llc	Nanoparticle comprising rapamycin and albumin as anticancer agent
US8022216B2 (en)	2007-10-17	2011-09-20	Wyeth Llc	Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof
DK2310011T3 (en)	2008-06-17	2013-10-14	Wyeth Llc	ANTINEOPLASTIC COMBINATIONS CONTAINING HKI-272 AND VINORELBINE
KR101434009B1 (en)	2008-08-04	2014-08-25	와이어쓰 엘엘씨	Antineoplastic combinations of 4-anilino-3-cyanoquinolines and capecitabine
US9211291B2 (en)	2009-04-06	2015-12-15	Wyeth Llc	Treatment regimen utilizing neratinib for breast cancer
CN103721189A (en) *	2013-12-27	2014-04-16	刘玉含	Meningeoma nursing medicine and preparation method thereof
CN105168204A (en) *	2015-09-06	2015-12-23	江志鑫	Pharmaceutical composition containing mitomycin and capable of resisting colon cancer
CN119732959A (en) *	2024-12-31	2025-04-01	吉林大学	Application of preparations with mTOR inhibitory ability in preparing anti-tumor combined pharmaceutical compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5066493A (en) *	1978-11-03	1991-11-19	American Home Products Corporation	Rapamycin in treatment of tumors
US4401653A (en) *	1981-03-09	1983-08-30	Ayerst, Mckenna & Harrison Inc.	Combination of rapamycin and picibanil for the treatment of tumors
EP0525960B1 (en) *	1991-06-18	1996-03-20	American Home Products Corporation	Use of rapamycin for the treatment of adult T-cell leukemia/lymphoma
TWI286074B (en) *	2000-11-15	2007-09-01	Wyeth Corp	Pharmaceutical composition containing CCI-779 as an antineoplastic agent
EP2269603B1 (en) *	2001-02-19	2015-05-20	Novartis AG	Treatment of breast tumors with a rapamycin derivative in combination with exemestane

2002
- 2002-05-29 SG SG200507698-9A patent/SG153647A1/en unknown
- 2002-05-29 AU AU2002259309A patent/AU2002259309B2/en not_active Ceased
- 2002-05-29 EA EA200301319A patent/EA007530B1/en not_active IP Right Cessation
- 2002-05-29 BR BR0210101-7A patent/BR0210101A/en not_active Application Discontinuation
- 2002-05-29 WO PCT/US2002/016737 patent/WO2002098416A2/en not_active Ceased
- 2002-05-29 JP JP2003501455A patent/JP2004532883A/en not_active Withdrawn
- 2002-05-29 PL PL02367267A patent/PL367267A1/en not_active Application Discontinuation
- 2002-05-29 KR KR1020037015721A patent/KR100875611B1/en not_active Expired - Fee Related
- 2002-05-29 CN CNB02811048XA patent/CN100496485C/en not_active Expired - Fee Related
- 2002-05-29 HU HU0400006A patent/HUP0400006A2/en unknown
- 2002-05-29 NZ NZ529877A patent/NZ529877A/en unknown
- 2002-05-29 IL IL15880002A patent/IL158800A0/en unknown
- 2002-05-29 EP EP02729310A patent/EP1392286A2/en not_active Ceased
- 2002-05-29 MX MXPA03010907A patent/MXPA03010907A/en not_active Application Discontinuation
- 2002-05-29 CA CA002447732A patent/CA2447732A1/en not_active Abandoned
2003
- 2003-11-26 CO CO03104435A patent/CO5540294A2/en not_active Application Discontinuation
- 2003-11-28 NO NO20035317A patent/NO20035317L/en not_active Application Discontinuation
2008
- 2008-06-18 AU AU2008202690A patent/AU2008202690A1/en not_active Abandoned

Also Published As

Publication number	Publication date
EA007530B1 (en)	2006-10-27
EP1392286A2 (en)	2004-03-03
BR0210101A (en)	2004-06-08
CA2447732A1 (en)	2002-12-12
NZ529877A (en)	2006-08-31
KR100875611B1 (en)	2008-12-24
WO2002098416A3 (en)	2003-03-13
IL158800A0 (en)	2004-05-12
KR20040025923A (en)	2004-03-26
PL367267A1 (en)	2005-02-21
CN100496485C (en)	2009-06-10
HUP0400006A2 (en)	2004-04-28
JP2004532883A (en)	2004-10-28
AU2002259309B2 (en)	2008-05-01
EA200301319A1 (en)	2004-04-29
NO20035317L (en)	2003-12-22
CN1646120A (en)	2005-07-27
SG153647A1 (en)	2009-07-29
MXPA03010907A (en)	2004-02-17
AU2008202690A1 (en)	2008-07-10
CO5540294A2 (en)	2005-07-29
WO2002098416A2 (en)	2002-12-12

Publication	Publication Date	Title
DK1414438T3 (en)	2006-03-27	Antineoplastic combinations
IS7291A (en)	2004-06-01	Marked kirni
DE50204184D1 (en)	2005-10-13	ESPRESSOBRÜHEINRICHTUNG
ATE524462T1 (en)	2011-09-15	C5-MODIFIED INDAZOLYLPYRROLOTRIAZINES
DE50214313D1 (en)	2010-05-12	KOAXIALMAGENTVENTIL
DE50208022D1 (en)	2006-10-12	WISCHBLATT
DE50204386D1 (en)	2006-02-09	Kreuztransducer
DE50212173D1 (en)	2008-06-12	sgängern
DE50103741D1 (en)	2004-10-28	Shaft-hub-connection
DE50206021D1 (en)	2006-05-04	SCHLAUCHKLEMME
DE50209238D1 (en)	2007-02-22	KUGELGELENK
ATE335486T1 (en)	2006-09-15	HYDRAZONO-MALONITRILE
DE50204551D1 (en)	2005-11-17	KUGELGELENK
DE50211604D1 (en)	2008-03-13	Chlag
DE50209410D1 (en)	2007-03-22	KUGELGELENK
NO20035317L (en)	2003-12-22	Antineoplastic combinations
DE50208372D1 (en)	2006-11-23	Cupboard-mounting
DE50211290D1 (en)	2008-01-10	HANDZANGE
DE50204794D1 (en)	2005-12-08	KUGELGELENK
DE50203984D1 (en)	2005-09-22	KUGELGELENK
DE50203412D1 (en)	2005-07-21	SCHWENKKOLBENVERDRÄNGER
DE50208029D1 (en)	2006-10-12	KUGELGELENK
ATE355059T1 (en)	2006-03-15	ISOXAZOLOPYRIDINONES
DE50201862D1 (en)	2005-01-27	MESSWANDLER
DE50203093D1 (en)	2005-06-16	LOSRADLAGER

Legal Events

Date	Code	Title	Description
2010-12-27	FC2A	Withdrawal, rejection or dismissal of laid open patent application